
|Articles|June 6, 2018
What every urologist needs to know about SpaceOAR® hydrogel
Advertisement
Study data has shown that SpaceOAR® hydrogel significantly improves quality of life for patients with prostate cancer who have undergone radiotherapy. But what does it take to implement this procedure into routine practice, and what can urologists expect regarding reimbursement?
In this supplement, practicing urologists will share perspectives on this procedure, addressing topics that include:
Advertorial Supported by:
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Kristen Scarpato, MD, on combination strategies in BCG-naïve NMIBC
2
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
3
Farah Rahman, MD, on monitoring resident wellness using biofeedback
4
Amanda North, MD, recaps SWIU 2026 session on imposter syndrome
5






